IMC Chicago
ADMA icon

IMC Chicago’s ADMA Biologics ADMA Stock Holding History

IMC Chicago’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Sell
44,092
-17,983
-29% -$164K ﹤0.01% 4986
2026
Q1 		$559K Buy
62,075
+40,964
+194% +$646K ﹤0.01% 3924
2025
Q4 		$385K Sell
21,111
-722
-3% -$12.2K ﹤0.01% 3644
2025
Q3 		$320K Sell
21,833
-5,773
-21% -$99K ﹤0.01% 3387
2025
Q2 		$503K Buy
+27,606
New +$563K ﹤0.01% 2863

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

IMC Chicago's ADMA Position: Q2 2026 in Review

IMC Chicago reduced its ADMA Biologics (ADMA) stake by 29% in Q2 2026, selling an estimated $164K and leaving 44,092 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #4986.

IMC Chicago first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $559K in Q1 2026. 131 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • IMC Chicago held 44,092 shares of ADMA Biologics worth $369K as of Q2 2026.
  • IMC Chicago sold 17,983 ADMA Biologics shares in Q2 2026, an estimated $164K.
  • ADMA Biologics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4986 holding.
  • IMC Chicago first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • IMC Chicago's ADMA Biologics position peaked at $559K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.